Breaking News, Collaborations & Alliances

Thermo Fischer Scientific and Symphogen Extend Collaboration

Supports biopharmaceutical discovery and development, aiding the creation of new cancer treatments.

Author Image

By: Charlie Sternberg

Associate Editor

Thermo Fisher Scientific and Symphogen, an affiliate of the antibody center of excellence within the international pharmaceutical company Servier, have extended their collaboration to provide biopharmaceutical discovery and development laboratories for efficient characterization of complex therapeutic proteins.   Since the collaboration began in 2018, Symphogen has adopted new instruments and software to improve data quality and processes to develop, test and routinely implement platform workf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters